You are on page 1of 2

21136 Federal Register / Vol. 73, No.

76 / Friday, April 18, 2008 / Notices

Dated: April 11, 2008. DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
Tim Hack, HUMAN SERVICES HUMAN SERVICES
Deputy Director, Office of Policy, Planning
and Evaluation, National Center for Centers for Disease Control and Centers for Disease Control and
Environmental Health/Agency for Toxic Prevention Prevention
Substances and Disease Registry.
Disease, Disability, and Injury Disease, Disability, and Injury
[FR Doc. E8–8167 Filed 4–17–08; 8:45 am]
Prevention and Control Special Prevention and Control Special
BILLING CODE 4163–70–P
Emphasis Panel (SEP): Monitoring Emphasis Panel (SEP): Survey of
Hospitalizations and Outpatient Visits Community Support Interventions for
for Pneumonia and Other Non-Invasive Mammography Screenings, Potential
DEPARTMENT OF HEALTH AND Extramural Project (PEP) 2008–R–13
HUMAN SERVICES Pneumonococcal Diseases by Using
National Databases, Potential In accordance with Section 10(a)(2) of
Centers for Disease Control and Extramural Project (PEP) 2008–R–17 the Federal Advisory Committee Act
Prevention (Pub. L. 92–463), the Centers for Disease
In accordance with Section 10(a)(2) of Control and Prevention (CDC)
Disease, Disability, and Injury the Federal Advisory Committee Act announces the aforementioned meeting.
Prevention and Control Special (Pub. L. 92–463), the Centers for Disease Time and Date: 1 p.m.–2:30 p.m., May 20,
Emphasis Panel (SEP): Epidemiology Control and Prevention (CDC) 2008 (Closed).
of Carbapenemase-Producing announces the aforementioned meeting. Place: Teleconference.
Enterobacteriaceae in a Healthcare Status: The meeting will be closed to the
Time and Date: 1 p.m.–2:30 p.m., May 19, public in accordance with provisions set
Setting, Potential Extramural Projects 2008 (Closed). forth in Section 552b(c)(4) and (6), Title 5
(PEP) 2008–R–24 Place: Teleconference. U.S.C., and the Determination of the Director,
Status: The meeting will be closed to the Management Analysis and Services Office,
In accordance with Section 10(a)(2) of public in accordance with provisions set CDC, pursuant to Public Law 92–463.
the Federal Advisory Committee Act forth in Section 552b(c)(4) and (6), Title 5 Matters to be Discussed: The meeting will
(Pub. L. 92–463), the Centers for Disease U.S.C., and the Determination of the Director, include the review, discussion, and
Control and Prevention (CDC) Management Analysis and Services Office, evaluation of ‘‘Survey of Community Support
announces the aforementioned meeting. CDC, pursuant to Public Law 92–463. Interventions for Mammography Screenings,
Matters to be Discussed: The meeting will PEP 2008–R–13.’’
Time and Date: 1 p.m.–2 p.m., May 15, Contact Person for More Information:
2008 (Closed). include the review, discussion, and
Linda Shelton, Program Specialist,
Place: Teleconference. evaluation of ‘‘Monitoring Hospitalizations Coordinating Center for Health and
Status: The meeting will be closed to the and Outpatient Visits for Pneumonia and Information Service, Office of the Director,
public in accordance with provisions set other Non-Invasive Pneumonococcal CDC, 1600 Clifton Road, NE., Mailstop E21,
forth in Section 552b(c)(4) and (6), Title 5 Diseases by Using National Databases, PEP Atlanta, GA 30333, Telephone (404) 498–
U.S.C., and the Determination of the Director, 2008–R–17.’’ 1194.
Management Analysis and Services Office, Contact Person for More Information: The Director, Management Analysis and
CDC, pursuant to Public Law 92–463. Linda Shelton, Program Specialist, Services Office, has been delegated the
Coordinating Center for Health and authority to sign Federal Register notices
Matters to be Discussed: The meeting will
Information Service, Office of the Director, pertaining to announcements of meetings and
include the review, discussion, and other committee management activities, for
evaluation of ‘‘Epidemiology of CDC, 1600 Clifton Road, NE., Mailstop E21,
both CDC and the Agency for Toxic
Carbapenemase-Producing Atlanta, GA 30333, Telephone (404) 498–
Substances and Disease Registry.
Enterobacteriaceae in a Healthcare Setting, 1194.
The Director, Management Analysis and Dated: April 10, 2008.
PEP 2008–R–24.’’
Contact Person for More Information: Services Office, has been delegated the Elaine L. Baker,
Linda Shelton, Program Specialist, authority to sign Federal Register notices Director, Management Analysis and Services
Coordinating Center for Health and pertaining to announcements of meetings and Office, Centers for Disease Control and
Information Service, Office of the Director, other committee management activities, for Prevention.
CDC, 1600 Clifton Road, NE., Mailstop E21, both CDC and the Agency for Toxic [FR Doc. E8–8357 Filed 4–17–08; 8:45 am]
Atlanta, GA 30333, Telephone (404) 498– Substances and Disease Registry. BILLING CODE 4163–18–P
1194. Dated: April 10, 2008.
The Director, Management Analysis and Elaine L. Baker,
Services Office, has been delegated the DEPARTMENT OF HEALTH AND
Director, Management Analysis and Services HUMAN SERVICES
authority to sign Federal Register notices
Office, Centers for Disease Control and
pertaining to announcements of meetings and
Prevention. Centers for Disease Control and
other committee management activities, for
[FR Doc. E8–8356 Filed 4–17–08; 8:45 am] Prevention
both CDC and the Agency for Toxic
Substances and Disease Registry. BILLING CODE 4163–18–P
Disease, Disability, and Injury
Dated: April 10, 2008. Prevention and Control Special
Elaine L. Baker, Emphasis Panel (SEP): The Effect of
Director, Management Analysis and Services Prenatal Bleeding on Pregnancy
Office, Centers for Disease Control and Outcomes in Women With a Previously
pwalker on PROD1PC71 with NOTICES

Prevention. Undiagnosed Bleeding Disorder,


[FR Doc. E8–8355 Filed 4–17–08; 8:45 am] Potential Extramural Project (PEP)
2008–R–27
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act

VerDate Aug<31>2005 17:38 Apr 17, 2008 Jkt 214001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1
Federal Register / Vol. 73, No. 76 / Friday, April 18, 2008 / Notices 21137

(Pub. L. 92–463), the Centers for Disease evaluation of ‘‘Impact of Cultural and other committee management activities, for
Control and Prevention (CDC) Socioeconomic Factors on Post-Treatment both CDC and the Agency for Toxic
announces the aforementioned meeting. Surveillance among African Americans with Substances and Disease Registry.
Colorectal Cancer, PEP 2008–R–03.’’
Time and Date: 1 p.m.–2 p.m., May 14, Contact Person for More Information: Dated: April 10, 2008.
2008 (Closed). Linda Shelton, Program Specialist, Elaine L. Baker,
Place: Teleconference. Coordinating Center for Health and Director, Management Analysis and Services
Status: The meeting will be closed to the Information Service, Office of the Director, Office, Centers for Disease Control and
public in accordance with provisions set CDC, 1600 Clifton Road, NE., Mailstop E21, Prevention.
forth in Section 552b(c) (4) and (6), Title 5 Atlanta, GA 30333, Telephone (404) 498–
U.S.C., and the Determination of the Director, 1194. [FR Doc. E8–8369 Filed 4–17–08; 8:45 am]
Management Analysis and Services Office, The Director, Management Analysis and BILLING CODE 4163–18–P
CDC, pursuant to Public Law 92–463. Services Office, has been delegated the
Matters to be Discussed: The meeting will authority to sign Federal Register notices
include the review, discussion, and pertaining to announcements of meetings and DEPARTMENT OF HEALTH AND
evaluation of ‘‘The Effect of Prenatal other committee management activities, for HUMAN SERVICES
Bleeding on Pregnancy Outcomes in Women both CDC and the Agency for Toxic
with a Previously Undiagnosed Bleeding Substances and Disease Registry. Centers for Disease Control and
Disorder, PEP 2008–R–27.’’
Dated: April 9, 2008. Prevention
Contact Person for More Information:
Linda Shelton, Program Specialist, Elaine L. Baker,
Coordinating Center for Health and Director, Management Analysis and Services Disease, Disability, and Injury
Information Service, Office of the Director, Office, Centers for Disease Control and Prevention and Control Special
CDC, 1600 Clifton Road, NE., Mailstop E21, Prevention. Emphasis Panel (SEP): Evaluation of
Atlanta, GA 30333, Telephone (404) 498– [FR Doc. E8–8368 Filed 4–17–08; 8:45 am] the Immune Response to a Modified
1194. BILLING CODE 4163–18–P Dosing Schedule for the Quadrivalent
The Director, Management Analysis and Human Papillomavirus (HPV) Vaccine,
Services Office, has been delegated the Potential Extramural Projects (PEP)
authority to sign Federal Register notices
DEPARTMENT OF HEALTH AND 2008–R–22
pertaining to announcements of meetings and
other committee management activities, for HUMAN SERVICES
both CDC and the Agency for Toxic In accordance with Section 10(a)(2) of
Substances and Disease Registry. Centers for Disease Control and the Federal Advisory Committee Act
Prevention (Pub. L. 92–463), the Centers for Disease
Dated: April 10, 2008.
Control and Prevention (CDC)
Elaine L. Baker, Disease, Disability, and Injury announces the aforementioned meeting.
Director, Management Analysis and Services Prevention and Control Special
Office, Centers for Disease Control and Emphasis Panel (SEP): A Time And Date: 1 p.m.–2 p.m., May 15,
Prevention. Retrospective Evaluation of Patterns of 2008 (Closed).
[FR Doc. E8–8363 Filed 4–17–08; 8:45 am] Care for American Indian and Alaska Place: Teleconference.
Status: The meeting will be closed to the
BILLING CODE 4163–18–P Native Men With Elevated Prostate
public in accordance with provisions set
Specific Antigen, Potential Extramural
forth in Section 552b(c)(4) and (6), Title 5
Project (PEP) 2008–R–15
U.S.C., and the Determination of the Director,
DEPARTMENT OF HEALTH AND
In accordance with Section 10(a)(2) of Management Analysis and Services Office,
HUMAN SERVICES
the Federal Advisory Committee Act CDC, pursuant to Public Law 92–463.
Centers for Disease Control and (Pub. L. 92–463), the Centers for Disease Matters to be Discussed: The meeting will
Prevention Control and Prevention (CDC) include the review, discussion, and
announces the aforementioned meeting: evaluation of ‘‘Evaluation of the Immune
Disease, Disability, and Injury Response to a Modified Dosing Schedule for
Time and Date: 1 p.m.–2:30 p.m., May 19, the Quadrivalent HPV Vaccine, PEP 2008–R–
Prevention and Control Special 2008 (Closed).
Emphasis Panel (SEP): Impact of 22.’’
Place: Teleconference.
Cultural and Socioeconomic Factors Contact Person for More Information:
Status: The meeting will be closed to the
public in accordance with provisions set Linda Shelton, Program Specialist,
on Post-Treatment Surveillance among
forth in Section 552b(c)(4) and (6), Title 5 Coordinating Center for Health and
African Americans with Colorectal
U.S.C., and the Determination of the Director, Information Service, Office of the Director,
Cancer, Potential Extramural Project CDC, 1600 Clifton Road, NE., Mailstop E21,
(PEP) 2008–R–03 Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463. Atlanta, GA 30333, Telephone (404) 498–
In accordance with Section 10(a)(2) of Matters to be Discussed: The meeting will 1194.
the Federal Advisory Committee Act include the review, discussion, and The Director, Management Analysis and
(Pub. L. 92–463), the Centers for Disease evaluation of ‘‘A Retrospective Evaluation of Services Office, has been delegated the
Control and Prevention (CDC) Patterns of Care for American Indian and authority to sign Federal Register notices
Alaska Native Men with Elevated Prostate pertaining to announcements of meetings and
announces the aforementioned meeting. Specific Antigen, PEP 2008–R–15.’’ other committee management activities, for
Time and Date: 1 p.m.–3 p.m., May 29, Contact Person for More Information: both CDC and the Agency for Toxic
2008 (Closed). Linda Shelton, Program Specialist, Substances and Disease Registry.
Place: Teleconference. Coordinating Center for Health and
Status: The meeting will be closed to the Information Service, Office of the Director, Dated: April 10, 2008.
public in accordance with provisions set CDC, 1600 Clifton Road, NE., Mailstop E21, Elaine L. Baker,
pwalker on PROD1PC71 with NOTICES

forth in Section 552b(c)(4) and (6), Title 5 Atlanta, GA 30333, Telephone (404) 498–
Director, Management Analysis and Services
U.S.C., and the Determination of the Director, 1194.
Office, Centers for Disease Control and
Management Analysis and Services Office, The Director, Management Analysis and
Prevention.
CDC, pursuant to Public Law 92–463. Services Office, has been delegated the
Matters to be Discussed: The meeting will authority to sign Federal Register notices [FR Doc. E8–8370 Filed 4–17–08; 8:45 am]
include the review, discussion, and pertaining to announcements of meetings and BILLING CODE 4163–18–P

VerDate Aug<31>2005 17:38 Apr 17, 2008 Jkt 214001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1